“Who on the executive team has brought a fda approved
“Who on the executive team has brought a fda approved drug to market before . That has grossed over 1 billion dollars . And been distributed worldwide . If Cytodyn is going to do that , I think we need someone that has done it before . Imho.”
Let me put this in simple terms for you: if the FDA approves leronlimab for COVID19 or HIV combo therapy later this year, NP and the rest of the CYDY crew will have brought a $1 billion drug to market. The Vyera deal covers distribution for HIV and there will be a distribution deal for COVID as well, which covers the remaining bases.
My point: we don’t need a new CEO to get to revenue as leronlimab is only an approval away from profits.
5
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
SCOR’s Actuarial Awards 2025: A Celebration of Innovation For nearly 30 years, SCOR has consistently honored exemplary research in actuarial science through its prestigious Actuarial Awards. Across six countries, these awards seek to inspire progress in the field, fostering advancements that improve our understanding of risk. Encouraging Research and Excellence The SCOR...
Continue Reading
Gentex Corporation Announces Fourth Quarter Earnings Release Gentex Corporation (NASDAQ: GNTX), a prominent supplier of advanced technology solutions including digital vision and connected car systems, has scheduled the release of its financial results for the fourth quarter and the year-end of 2024. Investors and stakeholders should mark their calendars for January 31,...
Continue Reading
Lockton's Expansion into Saudi Arabia Kansas City, Mo. – Lockton, recognized as the foremost privately held independent insurance brokerage, has embarked on a significant journey by expanding its operations into Saudi Arabia. This strategic move marks an essential development for Lockton, as it enhances its presence in the Middle East and aligns with its overarching...
Continue Reading
Partnership Between AMIAD and Dassault Aviation Leading the Way in Defense Innovation At a recent aerospace gathering, a significant partnership was forged as Pascale Lohat, the Senior Executive VP of Engineering at Dassault Aviation, and Bertrand Rondepierre, Director of the French Agency for AI in Defense (AMIAD), came together to sign a memorandum of understanding....
Continue Reading
Globus Medical, Inc. (NYSE: GMED) made waves in the orthopedic trauma sector back in 2024 with some heavy-hitting product launches. They introduced several groundbreaking systems, including the TENSOR™ Suture Button System—their first foray into suture-based innovations, which snagged 510(k) clearance from the FDA. You know that buzz on the trading floor? It was...
Continue Reading
